BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Integrated Biosystems Expands European Operations


10/19/2005 5:10:28 PM

NAPA, Calif., Nov. 10 /PRNewswire/ -- Integrated Biosystems, Inc. (IBI), the world's leading supplier of controlled freeze-thaw technology to the biopharmaceutical industry, today announced that a new customer support and applications laboratory has been opened in Aubagne, near Marseille, France.

The laboratory is located in the facilities of STEDIM with whom IBI has formed a strategic partnership to develop and commercialize its patented freeze-thaw technology incorporating disposable containers for use in the manufacturing of biopharmaceuticals. STEDIM is a global company with twenty-five years experience in the design and manufacture of single use plastic containers for the world's largest healthcare and pharmaceutical companies.

Although IBI has maintained a research and development operation in France to develop new products with STEDIM, the new laboratory, with increased staffing, will be the center for technical and applications support for the company's growing number of customers in Europe.

"Europe is a very important market for us," commented Richard Eagling, General Manager, Europe. "We see a lot of opportunity for growth. Our new facility is an essential component in providing excellent service and support for our growing customer base."

The new applications center complements IBI's existing commercial organization which is headquartered in Fribourg, Switzerland. The company already sells its controlled freeze-thaw technology to many of the large pharmaceutical manufacturers in Europe. The first product line, consisting of stainless steel vessels and thermal control units, sold under the CryoFin brand, was introduced about three years ago in Europe. The new Celsius product line, which will allow customers to perform their freeze-thaw operations using single use containers manufactured by STEDIM, is currently being launched worldwide. IBI's technology is already an integral part of the manufacturing process of many of the major biopharmaceutical products on the market today. More and more of these products are being manufactured in Europe to support the European healthcare needs. In addition, many of the large global pharmaceutical companies look to Europe for additional manufacturing capacity to meet the high growth projections of the biopharmaceutical industry.

As this market continues to experience rapid growth, IBI will be well positioned to provide the necessary technical support aimed at optimizing the efficiency of the biopharmaceutical industry's process development and manufacturing operations.

About Integrated Biosystems, Inc.

Integrated Biosystems, Inc. (IBI) is the world's leading supplier of patented technology and equipment for the controlled freezing, thawing and frozen storage of biopharmaceutical intermediates and final bulk drug substances. IBI's product portfolio includes freeze-thaw systems and related handling equipment for R&D, Pilot and Full-Scale Manufacturing. The technology has been used for over 10 years at leading Biotech and Biopharma contract manufacturers and is currently an integral part of the manufacture of a variety of leading biopharmaceuticals.

IBI is a private company headquartered in Napa, CA with European facilities in Fribourg (Switzerland) and Aubagne (France) and Engineering and Manufacturing operations in Springfield, MO.

For further information contact Richard Eagling, Vice-President Marketing and General Manager, Europe (reagling@integratedbio.com) or go to http://www.integratedbio.com/

About STEDIM.

STEDIM is the world's leading designer and manufacturer of single-use, sterile plastic bag systems, replacing traditional glassware and stainless steel vessels for the manufacture and the packaging of medical and biopharmaceutical products. Developed since 1990, STEDIM's biotechnology and drug delivery operations provide all types of bag systems, answering the needs of biopharmaceutical laboratories and manufacturers for the development, manufacturing process, packaging and administration of therapeutic drugs, from Drug Discovery to Drug Delivery.

STEDIM is headquartered in Aubagne, with major companies, in Concord, CA, and more than 15 countries. STEDIM is listed on the Second Marche of the Euronext Paris S.A. (France Euroclear code : 5326).

Further information is available at http://www.stedim.com/

Integrated Biosystems, Inc.

CONTACT: Richard Eagling of Integrated Biosystems, Inc, +1-707-226-9300,ext. 237


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->